XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · IEX Real-Time Price · USD
2.270
-0.070 (-2.99%)
Jul 2, 2024, 4:30 PM EDT - Market closed

XTL Biopharmaceuticals Market Cap

XTL Biopharmaceuticals has a market cap or net worth of $13.04 million as of July 2, 2024. Its market cap has increased by 117.30% in one year.

Market Cap
13.04M
Enterprise Value
11.03M
1-Year Change
117.30%
Ranking
Category
Stock Price
$2.27

Market Cap Chart

Since November 18, 2008, XTL Biopharmaceuticals's market cap has increased from $800.00K to $13.04M, an increase of 1,529.75%. That is a compound annual growth rate of 19.55%.

History

DateMarket Cap% Change
Jul 2, 202412.40M125.45%
Dec 29, 20235.50M-16.67%
Dec 30, 20226.60M-53.52%
Dec 31, 202114.20M-8.97%
Dec 31, 202015.60M122.86%
Dec 31, 20197.00M-21.35%
Dec 31, 20188.90M41.27%
Dec 29, 20176.30M270.59%
Dec 30, 20161.70M-56.41%
Dec 31, 20153.90M-15.22%
Dec 31, 20144.60M-31.34%
Dec 31, 20136.70M-55.63%
Dec 31, 201215.10M106.85%
Dec 30, 20117.30M160.71%
Dec 31, 20102.80M366.67%
Dec 31, 2009600.00K100.00%
Dec 31, 2008300.00K-62.50%
View and export this data all the way back to 2008. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition